In the cohort of Escudero et al. the most common autoantibody type was anti-LGI1 and the frequency of patients without evidence of CNS inflammation ranged from 25% (LGI1 antibodies) to 7% (GABABR antibodies). The gene discussed is LGI1; the disease is inflammation.